Newsfeeds - Spark Newswire

1 minute read

Earnings

Sangamo Therapeutics’s Earnings Outlook

November 2, 2:40 PM

Sangamo Therapeutics (NASDAQ:SGMO) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Sangamo Therapeutics will report an earnings per share (EPS) of $-0.35.

SGMO

3 minute read

Sangamo Therapeutics Announced Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Nine Patients

By Charles Gross

October 12, 4:48 AM

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today announced updated preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

SGMO

1 minute read

Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold

By Vandana Singh

September 23, 12:02 PM

Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …

PFE

4 minute read

Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 30, 6:07 PM

Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib)…

AMGN

1 minute read

Earnings

Recap: Sangamo Therapeutics Q2 Earnings

By Benzinga Insights

August 4, 5:22 PM

Sangamo Therapeutics (NASDAQ:SGMO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

SGMO

1 minute read

Sangamo Therapeutics Q2 EPS $(0.29) Beats $(0.35) Estimate, Sales $29.38M Beat $24.63M Estimate

By Benzinga Newsdesk

August 4, 5:06 PM

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.35) by 17.14 percent. This is a 12.12 percent increase over losses of $(0.33) per share

SGMO

34 minute read

Earnings

Earnings Scheduled For August 4, 2022

By Benzinga Insights

August 4, 4:23 AM

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

AAOI

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

July 19, 5:34 PM

Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.

ACRX